IMMUNOS THERAPEUTICS
ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
IMMUNOS THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2014-01-01
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.immunostherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
90.48 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Sitelinks Search Box Microsoft Exchange Online
Similar Organizations
ACS Biotech
ACS Biotech is an innovative start up in biotechnology
Annexin Pharmaceuticals
Annexin Pharmaceuticals AB (publ) is a world-leading biotechnology company.
Benchmark Holdings
Benchmark Holdings, a pioneering bioagtech company.
Biogenera
BIOGENERA SpA is a company operating in the biotechnology pharmaceutical sector.
Biorem Inc.
Biorem is a pioneer environmental biotechnology company.
Biotherapeutics
BioTherapeutics Inc. (BTI) is a pre-clinical stage company
CellmAbs
Pharmaceutical Company, Biotechnology
Chemotargets
Chemotargets is a computationally-oriented biotech company
Cloudbreak Therapeutics
Cloudbreak Therapeutics is a clinical stage biotechnology company
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Destiny Pharma
Destiny Pharma Ltd., a clinical stage pharmaceutical company
DiscoveryBioMed
DiscoveryBioMed, Inc. (DBM) is a life sciences and biotechnology company,
Emendo Biotherapeutics
Emendo Biotherapeutics is a biotechnology company
Enthera
Enthera is a biotech company whose mission is to find new therapeutic approaches to treat diabetes and gastrointestinal complication.
Ogeda
Ogeda is a privately owned clinical-stage drug discovery company.
Genmedica Therapeutics
Genmedica Therapeutics is a development-stage biotechnology company focused on type 2 diabetes.
Chance Pharmaceuticals
Chance Pharmaceuticals is a clinical-stage biotechnology company focusing on discovering.
Hebei Daan Pharmaceutical Co., Ltd
Hebei Daan Pharmaceutical Co., Ltd is a blood product manufacturing company.
Iltoo Pharma
ILTOO Pharma is a clinical-stage biotechnology company
Ingenza
Ingenza is an industrial biotechnology company.
LinKinVax
LinKinVax operates as a clinical-stage biotechnology company.
Lion TCR
Lion TCR is a clinical-stage biotechnology company.
MaxiVAX
MaxiVAX is a Swiss clinical-stage biotechnology company.
Metera Pharmaceuticals
Metera Pharmaceuticals is a preclinical stage biotechnology company.
OliX Pharmaceuticals
OliX is a clinical stage biotechnology company.
PositiveID
PositiveID is a life science and technology company.
Pulmobiotics
Pulmobiotics is a pre-clinical life sciences company.
Quell Therapeutics
Quell Therapeutics is a cell therapy company
Rain Therapeutics
Rain Therapeutics is a operator of a clinical stage biotechnology company.
RetiPharma
RetiPharma is a Danish Biotech company
SagaNatura
SagaNatura is a dynamic Icelandic biotech company.
Step Pharma
Step Pharma is a biotechnology company.
Summit Therapeutics
Summit Therapeutics is a clinical-stage drug discovery and development company.
The Brain Protection Company
The Brain Protection Company is a clinical-stage company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
TheraSource
TheraSource is a growing biotech company
UTC Therapeutics Inc.
UTC Therapeuticsโs vision is to become the leading global biotechnology company
Current Advisors List
Current Employees Featured
Founder
Investors List
Schroder Adveq
Schroder Adveq investment in Series B - ImmunOs Therapeutics
BioMedPartners
BioMedPartners investment in Series B - ImmunOs Therapeutics
Mission BioCapital
Mission BioCapital investment in Series B - ImmunOs Therapeutics
Pfizer Venture Investments
Pfizer Venture Investments investment in Series B - ImmunOs Therapeutics
PEAK6 Investments LLC
PEAK6 Investments LLC investment in Series B - ImmunOs Therapeutics
Fiscus Financial
Fiscus Financial investment in Series B - ImmunOs Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Series B - ImmunOs Therapeutics
GL Capital
GL Capital investment in Series B - ImmunOs Therapeutics
Lightspeed Venture Partners
Lightspeed Venture Partners investment in Series B - ImmunOs Therapeutics
Gimv
Gimv investment in Series B - ImmunOs Therapeutics
Key Employee Changes
Date | New article |
---|---|
2021-09-01 | ImmunOs Therapeutics Appoints Jeffrey Abbey as Chief Operating Officer, Establishes Clinical Advisory Board |
Official Site Inspections
http://www.immunostherapeutics.com
- Host name: www482.your-server.de
- IP address: 78.47.237.136
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin